KL-1156 Inhibitor

KL-1156 is an NF-kappaB inhibitor. It is also a lipopolysaccharide (LPS)-induced nitric oxide production inhibitor.

ef="javascript:void(0) rel="nofollow >
1 Cho M J H Par HJ Satees PUMA A Le J Yu J Ki Y Ha SB Jun JK Ch J Le K Kwa JH Le H Design synthesis an biologica evaluatio o benzofuran an 2,3-dihydrobenzofuran-2-carboxyli aci N-(substituted)phenylamid derivative a anticance agent an inhibitor o NF-kappaB Bioor Me Che Lett 201 Ju 15 5(12):2545-9 doi 10.1016/j.bmcl.2015.04.050 Epu 201 Ap 23 PubMe PMID 25953156 href="javascript:void(0) rel="nofollow >
2 Cho M Hwan YS PUMA AS J H Jeon Y O Y Le J Yu J Ki Y Ha SB Jun JK Ch J Le H Desig an synthesi o 3,4-dihydro-2H-benzo[]chromen derivative a potentia NF-kappa inhibitors Bioor Me Che Lett 201 Ju 1 4(11):2404-7 doi 10.1016/j.bmcl.2014.04.053 Epu 201 Ap 20 PubMe PMID 24792464 href="javascript:void(0) rel="nofollow >
3 Kwa JH Wo SW Ki TJ Y W Cho EH Ki SC Par H Ro E Jun JK Hwan BY Hon JT Ki Y Ch J Le H Synthesi an nuclea factor-kappa inhibitor activitie o 6 o 7-methylchroman-2-carboxyli aci N-(substituted phenylamides Arc Phar Res 200 Feb 2(2):167-75 doi 10.1007/s12272-009-1131-3 Epu 200 Ma 13 PubMe PMID 19280144 href="javascript:void(0) rel="nofollow >
4 Kwa JH Wo SW Ki TJ Ro E Kan HY Le HW Jun JK Hwan BY Ki Y Ch J Le H Synthesi o chroman-2-carboxyli aci N-(substituted)phenylamide an thei inhibitor effec o nuclea factor-kappa (NF-kappaB activation Arc Phar Res 200 Feb 1(2):133-41 PubMe PMID 18365680.

Small volumes of KL-1156, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS5774012 is an inhibitor targeting KL-1156.